Analysts are weighing in on Ophthotech Corp (NASDAQ:OPHT) and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), as shares of both healthcare firms fell sharply today, hitting new …
Credit Suisse analyst Alethia Young upgraded Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Neutral to Outperform with a price target of $165, marking a 32.
Piper Jaffray’s healthcare analyst Joshua Schimmer is out today with research notes on biotech giants Biogen Inc (NASDAQ:BIIB) and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), as shares of …
After a mostly red week, stocks gapped higher Friday morning with the latest jobs report. The jobless rate fell to 5.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is buying fellow ultra orphan drug developer Synageva Biopharma Corp (NASDAQ:GEVA) for $8.
